- Report
- February 2024
- 112 Pages
Europe
From €4307EUR$4,750USD£3,681GBP
- Report
- February 2024
- 75 Pages
Middle East, Africa
From €4307EUR$4,750USD£3,681GBP
- Report
- February 2024
- 70 Pages
Middle East, Africa
From €4307EUR$4,750USD£3,681GBP
- Report
- February 2024
- 70 Pages
United Kingdom
From €4307EUR$4,750USD£3,681GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4307EUR$4,750USD£3,681GBP
- Report
- February 2024
- 70 Pages
South Africa
From €4307EUR$4,750USD£3,681GBP
- Report
- February 2024
- 90 Pages
United Kingdom
From €4307EUR$4,750USD£3,681GBP
- Report
- February 2024
- 99 Pages
Japan
From €4307EUR$4,750USD£3,681GBP
- Report
- February 2024
- 90 Pages
Germany
From €4307EUR$4,750USD£3,681GBP
- Report
- February 2024
- 160 Pages
Philippines
From €2529EUR$2,789USD£2,161GBP
- Report
- August 2024
- 200 Pages
Global
From €3508EUR$3,869USD£2,998GBP
- Report
- May 2025
- 82 Pages
Denmark, Finland, ... Denmark, Finland, Iceland, Norway, Sweden
From €2584EUR$2,850USD£2,209GBP
- Report
- August 2024
- 115 Pages
Global
From €3581EUR$3,950USD£3,061GBP
- Report
- September 2025
- 60 Pages
Saudi Arabia
From €2312EUR$2,550USD£1,976GBP
- Report
- September 2025
- 60 Pages
China
From €2312EUR$2,550USD£1,976GBP
- Report
- March 2025
- 260 Pages
Middle East
From €2629EUR$2,900USD£2,247GBP
- Report
- March 2025
- 260 Pages
Africa
From €2629EUR$2,900USD£2,247GBP
- Report
- March 2025
- 210 Pages
Latin America
From €2629EUR$2,900USD£2,247GBP
- Report
- March 2025
- 840 Pages
Asia Pacific
From €2629EUR$2,900USD£2,247GBP
- Report
- March 2025
- 980 Pages
Europe
From €2629EUR$2,900USD£2,247GBP

The Self Monitoring Blood Glucose (SMBG) Devices market is a subset of the larger Glucose Testing market. SMBG Devices are used to measure and monitor blood glucose levels in individuals with diabetes. These devices are typically small, handheld, and battery-powered, and allow users to quickly and easily measure their glucose levels. SMBG Devices are often used in conjunction with other diabetes management tools, such as insulin pumps and continuous glucose monitors.
SMBG Devices are typically used by individuals with diabetes to monitor their glucose levels on a regular basis. This helps them to better manage their diabetes and reduce the risk of complications. Additionally, SMBG Devices can be used to detect hypoglycemia, or low blood sugar, which can be dangerous if left untreated.
Some companies in the SMBG Devices market include Abbott, Roche, LifeScan, and B. Braun. Show Less Read more